Study of Motexafin Gadolinium for the Treatment of Renal Cell (Kidney) Cancer

Clinical trial NCT00134186 · COMPLETED

Trial details

NCT number: NCT00134186
Sponsor: Pharmacyclics LLC.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Renal Cell Urogenital Neoplasms Urologic Neoplasms Kidney Neoplasms

Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.